BLOG

Dilantin Users May Be at Risk for Developing Stevens-Johnson Syndrome


California SJS Attorney
Studies have linked Dilantin to an increased risk of Stevens-Johnson Syndrome.

Patients who use Dilantin to control an epileptic condition may potentially have an increased risk of developing a serious skin condition known as Stevens-Johnson Syndrome.

Dilantin (phenytoin) is prescribed to treat patients who suffer from epileptic conditions, specifically those whose experience temporal lobe or grand mal seizures. Patients may also be treated with Dilantin following brain or spinal surgery to prevent post-op seizures. Dilantin is manufactured by Pfizer but there are several generic versions of the drug on the market, including Phenytek, Cerebyx, and Fosphenytoin.

In November 2008, the U.S. Food and Drug Administration issued an updated safety communication regarding Dilantin and its generic counterparts after research data indicated that the drug was potentially linked to an increased risk of serious skin reactions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). According to the FDA, the risk appeared to be greatest among Dilantin users of Asian descent who possessed a specific genetic allele known as HLA-B*1502. The FDA has also received numerous adverse event reports from patients of varying ethnic backgrounds who claim to have suffered serious side effects after using Dilantin.

Dilantin and Stevens-Johnson Syndrome

Stevens-Johnson Syndrome is marked by several specific symptoms, typically beginning with a fever, headache or sore throat. After a few days, the affected patient may begin to experience inflammation of the mucous membranes lining the eyes, nose, mouth or genital area. The victim will then begin to develop a rash which can spread quickly and cause the formation of blisters or lesions. The skin may take on a burned appearance and begin to slough off in the affected areas. Patients who develop SJS typically require hospitalization and extensive treatment to achieve a full recovery.

Toxic Epidermal Necrolysis Caused by Dilantin

Toxic epidermal necrolysis is a more severe form of SJS that results in death in approximately 35% of all cases. The symptoms of TEN are similar to those associated with Stevens-Johnson Syndrome and patients typically experience widespread tissue death in the upper lawyers of skin. Patients affected by TEN may experience significant scarring and are also more susceptible to infection, shock and organ failure.

Dilantin Side Effects Lawsuits

Pfizer, along with Parke Davis and Warner Lambert, has faced numerous lawsuits filed on behalf of victims and their families alleging that Dilantin caused serious complications stemming from Stevens-Johnson Syndrome, including at least one death. Patients who have developed SJS or TEN after using Dilantin may also be eligible to file a compensation claim. If you or a loved one was injured after taking Dilantin, an experienced Stevens-Johnson Syndrome attorney can assist you in protecting your legal rights.

Nadrich & Cohen, LLP specializes in representing victims in all 50 states who developed SJS or TEN after using Dilantin. For more information on filing a Dilantin side effects lawsuit, call 1-800-718-4658.

 

 

Do I Have A Case?

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

 

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

 

Why
Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


March 20, 2019

Valsartan Dangers: 3 Things You Should Know

Several drugs containing Valsartan have been  recalled in the U.S. because they contain impurities which may be cancer risks. You may be eligible for financial compensation if you took a drug containing Valsartan and have been diagnosed with cancer.


March 15, 2019

Expert Testifies Before House Subcommittee Regarding Talc Use And Ovarian Cancer Link

A United States House of Representatives subcommittee, on March 12th, 2019, looked into whether they should give the Food and Drug Administration (FDA) the power to more strictly regulate cosmetics, including talcum powder and products containing talc.

 

We are Personal Injury Lawyers representing accident victims throughout California.
For 30 years, the law firm of Nadrich & Cohen, LLP has helped injury victims
obtain the compensation they deserve.